Improving Prevention of Heart Disease in Latinos - Full Text View

Improving Prevention of Heart Disease in Latinos (LUCHAR)

This study is ongoing, but not recruiting participants.

First Received: January 10, 2005 Last Updated: April 27, 2009 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00101530

Purpose

The purpose of the study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, it seeks to improve the primary prevention of CVD in Hispanics.

Condition
Cardiovascular Diseases Heart Diseases Hypertension Diabetes Mellitus

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk

Resource links provided by NLM:

MedlinePlus related topics: Diabetes Heart Diseases High Blood Pressure

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	179
Study Start Date:	September 2004
Estimated Study Completion Date:	September 2009

Show Detailed Description

Eligibility

Ages Eligible for Study:	21 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

White and Latino patients in a safety net hospital

Criteria

Eligibility Criteria vary with each study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00101530

Locations

United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Principal Investigator:	Edward Havranek, MD	Denver Health and Hospital Authority
Principal Investigator:	Sheana Bull, PhD	University of Colorado Denver/HSC Aurora

More Information

No publications provided

Responsible Party:	Denver Health Medical Center ( Edward P. Havranek, MD )
Study ID Numbers:	1285, U01 HL79160, U01 HL79208
Study First Received:	January 10, 2005
Last Updated:	April 27, 2009
ClinicalTrials.gov Identifier:	NCT00101530 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Metabolic Diseases
Heart Diseases
Vascular Diseases
Diabetes Mellitus

Endocrine System Diseases
Cardiovascular Diseases
Glucose Metabolism Disorders
Hypertension

ClinicalTrials.gov processed this record on February 08, 2010